Portfolio company
Abcodia
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops biomarker-based blood tests and algorithms for the early detection of ovarian cancer in high-risk women.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AOA
This company develops non-invasive liquid biopsy blood tests for the early detection of ovarian cancer for healthcare providers and patients.
AOA Diagnostics
This biotech company develops AI-enabled liquid biopsy blood tests to detect early-stage ovarian cancer in symptomatic women.
Afynia
This company develops non-invasive blood tests to diagnose endometriosis for women and fertility clinics.
Voc Diagnostics
This company develops diagnostic instruments using machine learning and sensor technology to detect ovarian cancer from blood plasma samples for healthcare providers.
Aerion Bioscience
This company develops a blood test using a six-protein panel and algorithm to detect lung cancer in high-risk individuals.
Amadix
This company develops blood-based liquid biopsy tests for the early detection of colorectal, lung and pancreatic cancer in patients and healthcare settings.
nVision Medical
This company develops medical devices that collect cells from fallopian tubes to aid gynaecologists in the early diagnosis of ovarian cancer.
Pink Dx
The company develops non-invasive molecular diagnostic tests for the early detection of gynecological cancers for women and their healthcare providers.
